1 Papers
30 Citations
Lawrence Beall is an academic researcher from Johnson & Johnson Pharmaceutical Research and Development. The author has contributed to research in topics: Growth factor receptor inhibitor & Vascular endothelial growth factor A. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Synthesis and structure-activity relationships of pyrazine-pyridine biheteroaryls as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors.
Gee-Hong Kuo,Catherine Prouty,Aihua Wang,Stuart Emanuel,Alan Deangelis,Yan Zhang,Fengbin Song,Lawrence Beall,Peter J. Connolly,Prahba Karnachi,Xin Chen,Robert H. Gruninger,Jan L. Sechler,Angel R. Fuentes-Pesquera,Steven A. Middleton,Linda Jolliffe,William V. Murray +16 more
TL;DR: The low inhibition of these compounds to the growth of tumor cell lines, such as HeLa, HCT-116, and A375 further confirms that these VEGFR-2 inhibitors are not cytotoxic agents.
32